Latest Breaking News On - Kiniksa pharmaceuticals stock performance - Page 2 : comparemela.com

Dark Forest Capital Management LP Buys New Stake in Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA)

Dark Forest Capital Management LP Buys New Stake in Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Mark ragosaZurcher kantonalbank zurich cantonalbankJohnf paoliniKiniksa pharmaceuticals ltdYork mellon corpCharles schwab investment management incNews ratings for kiniksa pharmaceuticals dailyQuarter for kiniksa pharmaceuticalsKiniksa pharmaceuticalsGroup plcRoyal bankExchange commissionKiniksa pharmaceuticals profileKiniksa pharmaceuticals stock performanceDark forest capital managementFree report

Rice Hall James & Associates LLC Sells 9,758 Shares of Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA)

Rice Hall James & Associates LLC Sells 9,758 Shares of Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Johnf paoliniMichaelr megnaSecurities exchange commissionKiniksa pharmaceuticalsLazard asset managementExchange commissionAltshuler shaham ltdKiniksa pharmaceuticals ltdQuarter for kiniksa pharmaceuticalsInsider transactions at kiniksa pharmaceuticalsRoyal bankRice hall james associatesAdvisors incKiniksa pharmaceuticals stock performanceTower research capitalNews ratings for kiniksa pharmaceuticals daily

Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA) CFO Mark Ragosa Sells 12,000 Shares

Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA) CFO Mark Ragosa Sells 12,000 Shares
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Mark ragosaSphera funds managementKiniksa pharmaceuticals ltdKiniksa pharmaceuticals stock performanceNews ratings for kiniksa pharmaceuticals dailyKiniksa pharmaceuticalsGoldman sachs group incGet free reportCapital managementSachs groupStreet corpFunds managementWoodline partnersKiniksa pharmaceuticals daily

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Trading Up 3 3%

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) was up 3.3% during mid-day trading on Tuesday . The company traded as high as $18.00 and last traded at $17.91. Approximately 91,240 shares were traded during mid-day trading, a decline of 79% from the average daily volume of 433,778 shares. The stock had previously closed at […]

Johnf paoliniTower research capitalLazard asset managementKiniksa pharmaceuticals company profileNews ratings for kiniksa pharmaceuticals dailyKiniksa pharmaceuticalsHedge funds weigh in on kiniksa pharmaceuticalsKiniksa pharmaceuticals ltdRoyal bankKiniksa pharmaceuticals stock performanceJames investment research incAltshuler shaham ltdInsider transactions at kiniksa pharmaceuticalsGet free reportInvestment researchResearch capital

Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA) Short Interest Update

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Rating) saw a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 3,140,000 shares, an increase of 8.3% from the April 15th total of 2,900,000 shares. Based on an average daily trading volume, of 416,500 shares, the days-to-cover ratio […]

Granahan investment managementKiniksa pharmaceuticals stock performanceRenaissance technologiesKiniksa pharmaceuticalsNews ratings for kiniksa pharmaceuticals dailyKiniksa pharmaceuticals ltdAlphacentric advisorsHedge funds weigh in on kiniksa pharmaceuticalsJpmorgan chase coGet ratingInvestment managementCapital managementCentric advisorsKiniksa pharmaceuticals dailyNasdaq knsa